New scientific results from Dr. Ho's lab suggest that the South African and UK covid-19 variants are exhibiting signs of resistance to antibody treatments.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective.
A rapid, at-home COVID-19 test developed in David Ho's lab at Columbia University Vagelos College of Physicians and Surgeons, will receive funding from the New York City Economic Development Corp.